Akero Therapeutics (AKRO) Stock Chart & Stock Price History $47.60 -0.99 (-2.04%) Closing price 08/19/2025 04:00 PM EasternExtended Trading$47.99 +0.39 (+0.82%) As of 08/19/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Akero Therapeutics Stock Price Performance The Akero Therapeutics (AKRO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 78.01%, with a year-to-date return of 71.10%. In the past month, the stock has decreased 8.60%, reflecting recent market activity. As of the latest close, Akero Therapeutics traded at $47.60 with a market cap of $3.81 billion and volume of 523,545 shares. Five years ago, the stock traded at $34.44, representing a 38.21% increase over that period. At the time, it had a market cap of $1.25 billion and a volume of 122,652 shares. Receive AKRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.60%1 Month Performance-8.60%3 Month Performance+0.06%Year-To-Date Performance+71.10%1 Year Performance+78.01%5 Year Performance+38.21% AKRO Stock Chart for Wednesday, August, 20, 2025 AKRO Chart by TradingView Akero Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/19/2025$48.59$47.60-2.04%$48.60$47.41523,545 shs$3.81 billion08/18/2025$49.38$48.59-1.60%$49.58$48.46517,985 shs$3.89 billion08/15/2025$50.09$49.38-1.42%$50.10$45.572.19 million shs$3.95 billion08/14/2025$48.31$50.09+3.68%$50.19$47.311.15 million shs$4.01 billion08/13/2025$48.03$48.31+0.58%$48.78$47.59838,999 shs$3.86 billion08/12/2025$48.28$48.03-0.52%$48.80$47.10880,821 shs$3.83 billion08/11/2025$50.46$48.28-4.32%$50.04$47.371.19 million shs$3.85 billion08/08/2025$50.45$50.46+0.02%$51.39$49.441.06 million shs$4.02 billion08/07/2025$52.79$50.45-4.43%$53.02$49.891.72 million shs$4.02 billion08/06/2025$49.56$52.79+6.52%$52.98$50.002.59 million shs$4.21 billion Get the Latest News and Ratings for AKRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/05/2025$48.62$49.56+1.93%$49.82$48.071.03 million shs$3.95 billion08/04/2025$48.37$48.62+0.52%$49.92$48.321.19 million shs$3.88 billion08/01/2025$48.85$48.37-0.98%$49.33$47.34867,371 shs$3.86 billion07/31/2025$47.72$48.85+2.37%$49.36$47.501.02 million shs$3.89 billion07/30/2025$47.49$47.72+0.48%$48.75$46.921.16 million shs$3.80 billion07/29/2025$49.24$47.49-3.55%$50.04$47.08609,589 shs$3.79 billion07/28/2025$50.56$49.24-2.61%$50.69$49.21833,913 shs$3.93 billion07/25/2025$50.51$50.56+0.10%$50.83$49.61561,893 shs$4.03 billion07/24/2025$51.82$50.51-2.53%$52.05$50.381.01 million shs$4.03 billion07/23/2025$51.88$51.82-0.12%$52.55$51.25879,401 shs$4.13 billion07/22/2025$51.38$51.88+0.97%$51.98$50.60774,256 shs$4.14 billion07/21/2025$52.08$51.38-1.34%$52.81$51.12606,678 shs$4.10 billion07/18/2025$54.33$52.08-4.14%$54.87$51.90881,281 shs$4.15 billion Related Companies Genmab A/S Stock Price Chart Ascendis Pharma A/S Stock Price Chart Dr. Reddy's Laboratories Stock Price Chart Viatris Stock Price Chart QIAGEN Stock Price Chart Moderna Stock Price Chart Verona Pharma PLC American Depositary Share Stock Price Chart BridgeBio Pharma Stock Price Chart Blueprint Medicines Stock Price Chart Elanco Animal Health Stock Price Chart Receive AKRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AKRO) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWinning the AI WarWhat’s really driving the trade wars, reshoring, and sweeping executive orders? According to Porter Stansberry...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access